Skip to content

GSK plc

GLAXF GSK

CIK 0001131399 · Pharmaceutical Preparations · NYSE, OTC

  • GLAXOSMITHKLINE PLC (until 2022-05-16)
← back to feed
Revenue (TTM)
£32.67B
+4.1% YoY FY Dec 2025
Net Income (TTM)
£6.29B
+113.1% YoY FY Dec 2025
EPS Diluted (TTM)
£1.39
+123.2% YoY FY Dec 2025
Gross Margin
72.4%
FY Dec 2025
Operating Margin
24.3%
FY Dec 2025
Net Margin
19.3%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
£3.4B
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
4.32B sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings